ITEM 1. FINANCIAL STATEMENTS.
DAVI LUXURY BRAND GROUP, INC.
|
BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2012
|
|
September 30, 2012
|
|
|
(Unaudited)
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash
|
$
|
382,360
|
|
$
|
346,699
|
|
Accounts receivable, net
|
|
156,433
|
|
|
207,376
|
|
Inventory, net
|
|
72,969
|
|
|
74,534
|
|
Other current assets
|
|
7,132
|
|
|
2,192
|
|
Total current assets
|
|
618,894
|
|
|
630,801
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
22,568
|
|
|
18,442
|
|
Trademarks
|
|
50,000
|
|
|
50,000
|
|
Security deposit
|
|
21,600
|
|
|
21,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
$
|
713,062
|
|
$
|
720,843
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Accounts payable and accrued expenses
|
$
|
84,515
|
|
$
|
74,584
|
|
Accounts payable - related party
|
|
142,000
|
|
|
138,000
|
|
Deferred revenue
|
|
241,945
|
|
|
235,640
|
|
Convertible debt, net
|
|
10,000
|
|
|
5,000
|
|
Total current liabilities
|
|
478,460
|
|
|
453,224
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
478,460
|
|
|
453,224
|
|
|
|
|
|
|
|
|
Commitments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
Common stock, $0.001 par value; 75,000,000 shares authorized; 9,284,117 shares issued and outstanding at December 31, 2012 and September 30, 2012, respectively
|
|
9,284
|
|
|
9,284
|
|
Additional paid-in capital
|
|
1,034,148
|
|
|
1,034,148
|
|
Accumulated deficit
|
|
(808,830)
|
|
|
(775,813)
|
|
|
|
|
|
|
|
|
Total stockholders’ equity
|
|
234,602
|
|
|
267,619
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders’ equity
|
$
|
713,062
|
|
$
|
720,843
|
|
|
|
|
|
|
|
|
See accompanying notes to financial
statements
DAVI LUXURY BRAND GROUP, INC.
|
STATEMENTS OF OPERATIONS
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
Sales:
|
|
|
|
|
|
|
|
Royalty revenues
|
|
$
|
127,183
|
|
$
|
101,846
|
|
Product sales
|
|
|
27,478
|
|
|
9,862
|
Total sales
|
|
|
154,661
|
|
|
111,708
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
6,886
|
|
|
3,556
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
147,775
|
|
|
108,152
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
Wages and professional fees
|
|
|
79,218
|
|
|
143,249
|
|
Product development
|
|
|
1,640
|
|
|
15,000
|
|
General and administrative
|
|
|
94,531
|
|
|
46,439
|
Total costs and expenses
|
|
|
175,389
|
|
|
204,688
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(27,614)
|
|
|
(96,536)
|
|
|
|
|
|
|
|
|
Other expenses:
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(5,403)
|
|
|
-
|
|
Derivative expense
|
|
|
-
|
|
|
(3,521)
|
Total other expenses
|
|
|
(5,403)
|
|
|
(3,521)
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(33,017)
|
|
$
|
(100,057)
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - basic and diluted
|
|
|
9,284,117
|
|
|
7,509,000
|
|
|
|
|
|
|
|
|
Net loss per share - basic and diluted
|
|
$
|
(0.00)
|
|
$
|
(0.01)
|
See accompanying notes to financial statements
DAVI LUXURY BRAND GROUP, INC.
|
STATEMENTS OF CASH FLOWS
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
|
2012
|
|
|
2011
|
Cash flows from operating activities
|
|
|
|
|
Net loss
|
$
|
(33,017)
|
|
|
$
|
(100,057)
|
Adjustments to reconcile net loss to net cash used in operating activities
|
|
|
|
|
|
|
|
Depreciation
|
|
4,699
|
|
|
|
4,332
|
|
Stock based compensation
|
|
-
|
|
|
|
525
|
|
Amortization of debt discount
|
|
5,000
|
|
|
|
-
|
|
Derivative expense
|
|
-
|
|
|
|
3,521
|
Changes in operating assets and liabilities
|
|
|
|
|
|
|
|
Accounts receivable
|
|
50,943
|
|
|
|
(79,598)
|
|
Inventory
|
|
1,565
|
|
|
|
(56,245)
|
|
Other current assets
|
|
(4,940)
|
|
|
|
40,461
|
|
Accounts payable and accrued expenses
|
|
9,931
|
|
|
|
27,226
|
|
Accounts payable - related parties
|
|
4,000
|
|
|
|
13,000
|
|
Deferred revenue
|
|
6,305
|
|
|
|
83,005
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
44,486
|
|
|
|
(63,830)
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
Purchase of fixed assets
|
|
(8,825)
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
(8,825)
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Net change in cash
|
|
35,661
|
|
|
|
(63,830)
|
|
|
|
|
|
|
|
|
Cash, beginning of period
|
|
346,699
|
|
|
|
121,193
|
|
|
|
|
|
|
|
|
Cash, end of period
|
$
|
382,360
|
|
|
$
|
57,363
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
Income taxes paid
|
$
|
-
|
|
|
$
|
-
|
Interest paid
|
$
|
-
|
|
|
$
|
-
|
See accompanying notes to financial statements
DAVI LUXURY BRAND GROUP, INC.
NOTES TO
THE FINANCIAL STATEMENTS
December 31,
2012
(Unaudited)
Note 1
ORGANIZATION AND NATURE OF
OPERATIONS
Davi Luxury Brand Group, Inc. (“we,”
“us,” “our,” or the “Company”) was incorporated in the State of Nevada on July 26, 2007. The
Company
is a skin care/cosmetics business that offers a series of all-natural grape-based luxury branded
skin care products marketed under the “Davi Skin”, “Davi” and “Davi Napa” brand names. The
Company is currently targeting high-end luxury hotels and resorts, and in-flight and duty-free shops in order to establish our
brand as a luxury product used in first class locations. The Company’s goal is to expand our sales efforts to upscale department
stores, specialty retailers, prestige hotels, salons and spas. The Company receives royalty revenues through the licensing of its
products.
In addition, we have made our Le Grand Cru Face Cream and other products
available for sale through our
www.daviskin.com website and plan to offer more of our products online as they are developed.
Note 2
SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of Presentation
In the opinion of management, the accompanying
unaudited interim financial statements contain all adjustments necessary to present fairly the Company’s financial position
as of December 31, 2012, and the results of operations and cash flows for the three months ended December 31, 2012 and 2011. The
adjustments made are of a normal recurring nature. The accompanying unaudited financial statements have been prepared in conformity
with accounting principles generally accepted in the United States of America for interim financial information and with the instructions
to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally
accepted in the United States of America for complete financial statements. The operating results for the three months ended December
31, 2012 are not necessarily indicative of the results that may be expected for the year ending September 30, 2013. The accompanying
unaudited financial statements should be read in conjunction with the audited financial statements for the year ended September
30, 2012, which are included in our Annual Report on Form 10-K, and the "risk factors" described therein.
Going concern
These financial statements have been prepared
in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will
be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially
different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary
to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At
December 31, 2012, the Company had not yet achieved profitable operations, has an accumulated deficit of $808,830 since its inception,
has working capital of $140,434, and expects to incur further losses in the deployment of its business plan, all of which raise
substantial doubt about the Company's ability to continue as a going concern. The Company's ability to continue as a going concern
is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations
and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to
address this concern but considers that the Company will be able to obtain additional funds by continuing to receive royalty revenues
and by additional equity financing and/or related party advances. However, there is no assurance of additional funding being available.
Note 3
RELATED PARTY TRANSACTIONS
In order to preserve cash for other working
capital needs, the Company’s Chief Executive Officer and the Company’s former Chairman of the Board of Directors agreed
to accrue a portion of the amounts owed to them under their employment and consulting agreements. As of December 31, 2012, the
Company owed $142,000 for such accrued wages.
Note 4
CUSTOMER CONCENTRATIONS
During the three months
ended December 31, 2012 and 2011, 71% and 73%, respectively, of our sales were generated from royalty revenues under a license
agreement to provide DAVI branded products to passengers of Korean Air. The Company’s reliance on this licensing agreement
makes us vulnerable to the risk of a near-term severe impact. Should the licensee terminate the license agreement, our financial
condition could be materially and adversely affected, and our on-going operations could be severely hampered.
Note 5
CONVERTIBLE DEBT
On July 12, 2012, the Company issued a Convertible
Promissory Note in the principal amount of $20,000 (the “Convertible Note”) to an accredited investor (the “Holder”).
The Convertible Note bears interest at 8% per annum and is due in full on June 30, 2013 (the “Maturity Date”). The
Holder of the Convertible Note may at any time prior to the Maturity Date convert the outstanding principal balance of the Convertible
Note together with all accrued and unpaid interest into shares of our common stock at a conversion price equal to $0.10 per share
(subject to applicable antidilution adjustments). The number of shares of common stock that may be acquired by the Holder upon
any conversion of the Convertible Note is to be limited to the extent necessary to insure that, following such conversion, the
total number of shares of our common stock owned by the Holder does not exceed 9.9% of the total number of issued and outstanding
shares of our common stock.
As an incentive to
purchase the Convertible Note, we issued the Holder a warrant to purchase 250,000 shares of our common stock at a price of $0.10
per share. The warrant became exercisable at any time beginning January 1, 2013 and expires on June 30, 2013. The relative fair
value of the warrant was estimated to be $16,000 using the Black-Scholes option pricing model based on the following assumptions:
expected dividend yield 0%, expected volatility 385%, risk-free interest rate 0.2%, and expected life of 1 year.
The intrinsic value of the embedded beneficial
conversion feature of the Convertible Note and the warrant was determined to be $20,000. The intrinsic value of $20,000 was charged
to the note discount and credited to Additional Paid in Capital. The note discount is amortized over the term of the Convertible
Note and charged to interest expense. As of December 31, 2012, the discount on the Convertible Note totaled $10,000, and for the
three months ended December 31, 2012, interest expense related to such amortization totaled $5,000.
We reviewed the Convertible Note for evidence
of embedded derivative instruments, which may be required to be bifurcated from the associated host instrument and accounted for
separately as derivative instrument liabilities. Based on this review we noted no such embedded derivative instruments and concluded
that the Convertible Note was conventional convertible debt.
Note 6
EQUITY
Common Stock Warrants
Since inception, the Company has issued warrants
to purchase shares of the Company’s common stock to accredited investors.
A summary of the Company’s warrants activity
and related information for the three months ended December 31, 2012 is provided below:
Warrant Activity Table:
|
|
|
Number of
|
|
|
|
|
Warrants
|
|
|
|
|
|
|
Outstanding and exercisable at September 30, 2012
|
|
|
|
365,000
|
|
Warrants exercised
|
|
|
|
-
|
|
Warrants granted
|
|
|
|
-
|
|
Warrants expired
|
|
|
|
(115,000
|
)
|
Outstanding at December 31, 2012
|
|
|
|
250,000
|
|
Warrants Outstanding Table:
|
Stock Warrants as of December 31, 2012
|
|
|
Exercise
|
|
Warrants
|
|
Remaining
|
|
Warrants
|
|
|
Price
|
|
Granted
|
|
Life (Years)
|
|
Exercisable
|
|
|
|
|
|
|
|
|
|
|
$0.10
|
|
|
250,000
|
|
|
0.50
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 7
COMMITMENTS
As of January 18,
2011, the Company entered into a lease with Resco LP, a California limited partnership, the landlord of the office that the Company
is leasing. Under the lease, the Company occupies approximately 1,500 square feet of office space at 9426-9428 Dayton Way, Beverly
Hills, California. The lease term expires on January 31, 2016, unless earlier terminated in accordance with the lease. The Company’s
monthly rent expense under the lease is approximately $5,600 per month, plus payments of 10% of common area operating expenses.
The Company has the option to extend the term of the lease by two additional years.
ITEM 2. MANAGEMENT’S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Forward-looking statements
This Quarterly
Report, including any documents which may be incorporated by reference into this Quarterly Report, contains “Forward-Looking
Statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. All statements other than statements of historical fact are “Forward-Looking Statements”
for purposes of these provisions, including our plans to develop, market and sell new skincare products, and implement our growth
strategy, any projections of revenues or other financial items, any statements of the plans and objectives of management for future
operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or
performance, and any statements of assumptions underlying any of the foregoing. All Forward-Looking Statements included in this
document are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to
update any Forward-Looking Statement. In some cases, Forward-Looking Statements can be identified by the use of terminology such
as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,”
“believes,” “estimates,” “potential,” or “continue,” or the negative thereof or
other comparable terminology. These statements by their nature involve substantial risks and uncertainties, such as our ability
to establish our business and develop, market and sell new skincare products, and implement our growth strategy, certain of which
are beyond our control
.
Although we believe that the expectations reflected in the Forward-Looking Statements contained
herein are reasonable, should one or more of these risks or uncertainties materialize or should the underlying assumptions prove
incorrect, actual outcomes and results could differ materially from those indicated in the Forward-Looking Statements. Future financial
condition and results of operations, as well as any Forward-Looking Statements are subject to inherent risks and uncertainties,
including any other factors referred to in our press releases and reports filed with the Securities and Exchange Commission (the
"SEC"). All subsequent Forward-Looking Statements attributable to the Company or persons acting on its behalf are expressly
qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating
results are included in our Annual Report on Form 10-K, and the "risk factors" described therein, and elsewhere in this
Quarterly Report.
Introductory Comment
Throughout this
Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “the Company,” and
“our Company” refer to Davi Luxury Brand Group, Inc., a Nevada corporation.
Organizational History
Davi Luxury Brand Group,
Inc. was incorporated in the State of Nevada on July 26, 2007
under the name “
Dafoe Corp.
”
The
Company
is a skin care/cosmetics business that offers a series of all-natural grape-based luxury branded
skin care products marketed under the “Davi Skin”, “Davi” and “Davi Napa” brand names. We own
all of the rights to the “Davi Skin” brand, logo, website address and other marketing rights. The Company receives
sales and royalty revenues through the sale and licensing of our products. During January 2011, we changed our name to “Davi
Luxury Brand Group, Inc.” and moved our executive offices from Carson City, Nevada, to Beverly Hills, California.
On May 10, 2012,
we effected a reverse stock split of our outstanding shares of common stock on a 1-for-10 basis (the "Reverse Split")
and
a corresponding decrease in the number of shares of our common stock that we are authorized to issue
.
All common stock and per share information (other than par value) contained in this Quarterly Report has been adjusted to reflected
the foregoing stock split.
Plan of Operation and Current Business
We have developed
and are expanding our skin care line/cosmetics business based on a series of grape and botanical-based luxury branded skin care
products marketed under the “DAVI”, “DAVI SKIN” and “DAVI NAPA” brand names. We intend to develop,
manufacture and market a line of high quality skin care products that are sold as prestige products principally through limited
distribution channels to complement the images associated with the DAVI, DAVI SKIN and DAVI NAPA brands. We are currently targeting
high-end luxury hotels and resorts, and in-flight and duty-free shops in order to establish our brand as a luxury product used
in first class locations. Our goal is to expand the targeted scope of our sales efforts to upscale department stores, specialty
retailers, prestige hotels, salons and spas. In addition, we have made our Le Grand Cru Face Cream and other products available
for sale through our www.daviskin.com website and plan to offer more of our products online as they are developed.
Current Operations
and Business Arrangements.
Since having begun
our new business in January 2011, and in accordance with our business plan, we have commenced selling DAVI branded luxury skin
care products through the following arrangements:
Peninsula Hotels
.
In January 2011, we entered into an agreement with Gilchrist & Soames to provide Peninsula Hotels with our DAVI, DAVI SKIN
and DAVI NAPA branded in-room skin care and related amenities. The Peninsula Hotel chain purchases our DAVI, DAVI SKIN and DAVI
NAPA branded products directly from our manufacturer and pays us a fee for each product purchased. The DAVI, DAVI SKIN and DAVI
NAPA products are provided by all of the Peninsula Hotels to their hotel clients as in-room amenities. The Peninsula Hotel chain
currently uses these products at all of its nine existing Peninsula Hotels worldwide.
Korean Air--In
Flight Amenities
. In January 2011, we also entered into a multi-year agreement to be the exclusive First Class and Business
Class in-flight amenity provider for all Korean Air flights worldwide. Korean Air commenced providing DAVI and DAVI NAPA branded
amenity travel bags that contain DAVI skin care products to its First and Business Class passengers in May 2011. These products
are currently available on all Korean Air flights. Korean Air purchases the DAVI and DAVI NAPA amenity products directly from our
manufacturer and we receive a royalty fee for those products.
Korean Air--Direct
Product Sales
. In November 2011, we launched a sales program to sell our Le Grand Cru face cream directly to Korean Air’s
passengers. Korean Air has added our Davi Le Grand Cru luxury face cream to the products that it offers for sale on board its flights.
In addition, Korean Air has also included our Davi Le Grand Cru luxury face cream in the SKY SHOP Magazine that is distributed
to all passengers on its flights, and now offers our Davi Le Grand Cru face cream for sale on Korean Air’s on-line shop (www.cyberskyshop.com).
Korean Air purchases these products directly from us.
On-Line Sales
.
We currently maintain our corporate website at www.daviskin.com. During July 2011 we launched our e-commerce initiative on that
website by offering for sale our Davi Le Grand Cru luxury face cream. Since that time, we have added our Vine Fresh SPF 15 Lotion,
Moscato Purifying Cleanser and Harvest Mist Toner to our product lineup. We anticipate that we will include additional products
on our website during 2013.
LGHH License
Agreement.
On September 4, 2012, we entered into a Brand and Trademark License Agreement (the “LGHH License Agreement”)
with LG Household and Health Care, Ltd. (“LGHH”). Under the LGHH License Agreement, we granted LGHH an exclusive license
to manufacture, sell, market and distribute in Korea, Japan, China and other Asian markets DAVI branded women's and men's skin
care, cosmetics, hair care and other products. Under the 10-year LGHH License Agreement, LGHH has agreed to pay us a royalty based
on the DAVI branded products that it sells in the licensed territory, although LGHH has no obligation under the LGHH License Agreement
to sell any products. LGHH has commenced development of DAVI licensed products, but no such products have yet been commercially
released.
Results of Operations
Three Months Ended December 31, 2012 vs.
Three Months Ended December 31, 2011
Our revenues for the three
months ended December 31, 2012 (“Q1 2013”) increased by 38% compared with our revenues for the three months ended December
31, 2011 (“Q1 2012”), while operating expenses in Q1 2013 decreased by 14%. Our net loss in Q1 2013 is approximately
67% lower than it was in Q1 2012.
The following table represents our statements
of operations for the three months ended December 31, 2012 and 2011:
|
|
|
Three Months Ended December 31,
|
|
|
|
2012
|
|
2011
|
|
|
|
$
|
|
% of Revenues
|
|
$
|
|
% of Revenues
|
Sales:
|
|
|
|
|
|
|
|
|
|
|
|
Royalty revenues
|
|
$
|
127,183
|
|
82%
|
|
$
|
101,846
|
|
91%
|
|
Product sales
|
|
|
27,478
|
|
18%
|
|
|
9,862
|
|
9%
|
Total sales
|
|
|
154,661
|
|
100%
|
|
|
111,708
|
|
100%
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
6,886
|
|
4%
|
|
|
3,556
|
|
3%
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
147,775
|
|
96%
|
|
|
108,152
|
|
97%
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Wages and professional fees
|
|
|
79,218
|
|
51%
|
|
|
143,249
|
|
128%
|
|
Product development
|
|
|
1,640
|
|
1%
|
|
|
15,000
|
|
13%
|
|
General and administrative
|
|
|
94,531
|
|
61%
|
|
|
46,439
|
|
42%
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses
|
|
|
175,389
|
|
113%
|
|
|
204,688
|
|
183%
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(27,614)
|
|
(17%)
|
|
|
(96,536)
|
|
(86%)
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(5,403)
|
|
(3%)
|
|
|
-
|
|
-%
|
|
Derivative expense
|
|
|
-
|
|
-%
|
|
|
(3,521)
|
|
(3%)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other expenses
|
|
|
(5,403)
|
|
(3%)
|
|
|
(3,521)
|
|
(3%)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(33,017)
|
|
(20%)
|
|
$
|
(100,057)
|
|
(89%)
|
Sales
Royalty revenues
generated during Q1 2013 and Q1 2012 were the result of royalty agreements we entered into during early 2011 for the sale of DAVI
branded skin care products to Peninsula Hotels for use by their hotel clients as in-room amenities, and to Korean Air as on-board
amenities for use by Korean Air’s First Class and Business Class passengers. During Q1 2013 we generated approximately $127,000
of royalty revenues from DAVI branded products sold to the Peninsula Hotels and Korean Air, as compared to approximately $102,000
of royalty revenues during Q1 2012. The net increase of royalty revenues during Q1 2013 as compared to Q1 2012 is principally the
result of Korean Air purchasing more “DAVI” branded skin care products. Additionally, sales to Korean Air of our products
for re-sale on-board its flights to its passengers and through its Skyshop Magazine have increased during Q1 2013. We recognized
approximately $23,000 of revenues during Q1 2013, which had previously been deferred, related to sales of our Le Grand Cru face
cream on consignment to Korean Air for re-sale on-board and through its SKY SHOP Magazine. Sales of our DAVI NAPA skin care products
through our on-line store, www.daviskin.com, totaled approximately $4,500 in Q1 2013, compared to approximately $1,800 in Q1 2012.
We intend to offer additional products on our website during 2013.
Cost of Goods Sold
Cost of goods sold
during Q1 2013 totaled approximately $7,000 of which $4,500 relates to sales commissions paid on the purchase by Korean Air of
our Le Grand Cru Face cream for re-sale on-board and through its SKY SHOP Magazine. The balance of the cost of goods sold during
Q1 2013, as well as during Q1 2012, relates to the cost of our skin care products sold to Korean Air for re-sale in its SKY SHOP
Magazine and its on-line shop. Since both Peninsula Hotels and Korean Air purchase the DAVI branded hotel room amenities and skin
care products directly from our manufacturer, we did not have any cost of goods sold relating to royalty payments made to us under
our Peninsula Hotel and Korean Air agreements.
Wages and Professional Fees
Wages and professional
fees totaling approximately $79,000 during Q1 2013 consisted primarily of accounting and legal fees incurred in connection with
the preparation and filing with the SEC of our public company reports and wages payable to our Chief Executive Officer. The approximately
45% decrease of wages and professional fees incurred in Q1 2013 compared to such fees incurred in Q1 2012 is primarily attributable
to the resignation in February 2012 of our former Chief Financial Officer and the termination as of November 2012 of our consulting
arrangement with our former Chairman of the Board. We anticipate that we will have to hire additional employees and contractors
as our Company grows.
Product Development
Product development costs
incurred during Q1 2013 totaled approximately $2,000 and decreased 89% in comparison to such costs incurred in Q1 2012. The decrease
results from the termination by us of an agreement we entered into in November 2011 with a professional skincare formulator to
improve and enhance our existing skin care products and to develop additional skin care products. In exchange for these services,
we agreed to make twelve monthly payments of $15,000 each. We have since redirected our focus on establishing our product line
before moving forward with the skin care formulations, and are using the skincare formulator's services on an “as needed”
basis.
General and Administrative
Expenses
General and administrative
expenses totaled approximately $95,000 and $46,000 during Q1 2013 and Q1 2012, respectively. The net increase in Q1 2013 of such
costs, which consist primarily of our office rent expense, advertising in Korean Air’s SKY SHOP Magazine, travel costs primarily
for marketing and business development trips to Asia, inventory storage costs, depreciation and various corporate and office expenses,
is principally the result of increased outside services and marketing costs associated with our growing operations in Asia, and
for the purpose of expanding the same.
Other Expenses
Other expenses for
Q1 2013 totaled approximately $5,400 and consist primarily of the amortization of the beneficial conversion feature recognized
on $20,000 of convertible debt and related warrants of the Company. Other expenses for Q1 2012 of approximately $3,500 are the
result of a price protection feature included on 70,000 shares of common stock sold for $52,500 during August 2011 to an accredited
investor pursuant to a stock purchase agreement. The price protection feature attached to the shares is accounted for as a derivative
liability at the date of sale and adjusted to fair value through earnings at each reporting date. When the proceeds from the sale
of the shares were received in August 2011, the Company recognized a derivative liability of $23,520, which approximated the fair
value of the derivative on that date. At December 31, 2011, the approximate fair value of the derivative was $43,000, resulting
in a derivative expense of approximately $3,500.
Net Loss
Our net loss in
Q1 2013 and Q1 2012 totaled approximately $33,000 and $100,000, respectively. The substantial decrease in our net loss in Q1 2013
is primarily the result of increased royalty revenues and product sales and decreases in wages and professional fees, as discussed
above.
Liquidity and Capital
Resources
As of December 31,
2012, we had approximately $382,000 in cash, $237,000 of other current assets and working capital of $140,000 compared to approximately
$347,000 in cash, $284,000 of other current assets and working capital of $177,577 as of September 30, 2012. Included in our cash
balance as of December 31, 2012 was a non-refundable advance against future royalties of $250,000 (less foreign taxes withheld).
To date, our operating activities have been primarily financed from the sales of our securities, stockholder advances, contributed
capital and royalty payments received from sales of our skin care products to an international airline and a luxury hotel chain.
During Q1 2013, our net
loss decreased to $33,000 compared to a net loss of $100,000 in Q1 2012. We had net cash provided by operating activities of $44,000
in Q1 2013 compared to net cash used in operating activities of $64,000. The increase in the net cash provided by operating activities
resulted primarily from increases in proceeds received from our royalty agreement with Korean Air as well decreases in amounts
owed for wages and consulting fees due to the resignations of our former Chief Financial Officer in February 2012 and our former
Chairman of the Board in November 2012. As of December 31, 2012 we had approximately $156,000 in outstanding accounts receivable.
Net cash used in
investing activities in Q1 2013 was $8,825 and consisted primarily of payments for leasehold improvements to our office space.
The Company had no cash used in investing activities in Q1 2012.
The Company had no financing
activities during Q1 2013 or Q1 2012.
The funding raised
to date, together with the royalty and product sales revenues we received and expect to receive from Korean Air, the Peninsula
Hotel chain, LGHH, and other anticipated future revenues we expect to generate from sales of our skin care products through other
channels are expected to be sufficient to fund our working capital needs for the next twelve months. However, additional sources
of revenues may be needed to enable us to implement our business plan or to otherwise continue to grow. Accordingly, we expect
to have to raise additional financing to fund all of our expected additional product manufacturing costs and other anticipated
expenditures related to the roll-out of our retail products. Our business plan also calls for us to market our products through
other distribution channels, which will require us to incur additional marketing expenses. We expect to have to raise additional
funds to fund our retail sales and online marketing initiatives and to be able to engage in other distribution activities.
We presently do
not have any available credit, bank financing or other external sources of liquidity. Currently, our only source of revenues is
derived from the agreements that we have entered into with Korean Air and the Peninsula Hotels. Sales of our skincare products
to Korean Air and the Peninsula Hotels since the inception of the agreements through December 31, 2012 resulted in approximately
$760,000 of royalty revenue and $81,000 of product sales. Both arrangements may be terminated at any time. Further, although we
have recently entered into a license agreement with LGHH, as of the date of this Quarterly Report, no products have been developed
or sold in connection with this agreement. Accordingly, our ability to continue to receive revenues in the future from our principal
sources of current revenues is uncertain. Should any or all of these revenue sources terminate their arrangements with us, our
financial condition could be materially and adversely affected, and our on-going operations could be severely hampered. Additionally,
our general and administrative expenses are expected to increase, and we may have to incur additional product branding and marketing
expenses to further promote our business plan. As a result, despite our sale of an aggregate of $782,500 of common stock through
December 31, 2012, we believe that we will have to obtain additional capital from the sale of additional securities or by borrowing
funds from private lenders. There is no assurance that we will be successful in obtaining additional funding.
Our current status
as a micro-cap company that has limited operations is expected to make it difficult to obtain financing through the issuance of
equity or debt securities. If we issue additional equity or debt securities, stockholders may experience additional dilution or
the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If
additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations.
No assurance can be given that we will be able to obtain sufficient capital to meet our requirements.
Inflation and changing
prices have had no effect on our continuing operations over our two most recent fiscal years.
Off-balance sheet
arrangements
We have no off-balance
sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk
support or other benefits.
Critical accounting policies and estimates
There are no material changes
to the critical accounting policies and estimates described in the section entitled “Critical Accounting Policies and Estimates”
under Item 7 in our Annual Report on Form 10-K for the year ended September 30, 2012.